对EGFR阳性非小细胞肺癌的EGFR-TKIs的剂量减少:一项回顾性研究
Akira Mochizuki1, Hiroaki Matsumoto2, Yosuke Maezawa2
1Division of Hospital Pharmacy, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Mito, Japan.
Cancer diagnosis & prognosis
|March 4, 2025
概括
在非小细胞肺癌 (NSCLC) 患者中减少表皮生长因子受体 (EGFR) 氨酸激酶抑制剂 (TKI) 剂量是一个可行的选择. 剂量减少,通常是由于副作用,与EGFR突变NSCLC的总生存时间更长有关.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
背景情况:
- 表皮生长因子受体 (EGFR) 突变驱动非小细胞肺癌 (NSCLC).
- EGFR氨酸激酶抑制剂 (TKI) 改善了NSCLC的预后.
- 传统的剂量策略不适合EGFR-TKI.
研究的目的:
- 描述需要降低EGFR-TKI剂量的患者.
- 评估EGFR-TKI剂量减少对NSCLC生存结果的影响.
主要方法:
- 对165名EGFR突变NSCLC患者的回顾性评估,这些患者接受了EGFR-TKI治疗.
- 分析患者特征,治疗细节和生存数据.
- 多变量分析以确定影响生存的因素.
主要成果:
- 67.3%的患者接受了EGFR-TKI剂量降低,通常是由于腹和皮疹等副作用.
- 接受剂量减少的患者的身体表面积较小,性能状况更好.
- 剂量减少组的整体存活时间明显长 (p=0.011).
- 多变量分析发现TKI剂量减少是有利的预后因素 (HR=0.68,p=0.046).
结论:
- 减少EGFR-TKI的剂量是管理EGFR突变NSCLC的不良影响的实用方法.
- 降低剂量可以安全地实施,特别是在老年或体重不足的患者中.
- 对于出现不良事件的患者,请毫不犹地考虑降低剂量.
相关概念视频
Renal Failure: Dose Adjustments
54
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
54
Dosage Regimen: Fixed Dose
1.8K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.8K
Rational Dosage Regimen: Maintenance Dose and Loading Dose
3.8K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
3.8K
Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Dose-Response Relationship: Potency and Efficacy
4.1K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.1K


